Core Viewpoint - NeuroOne Medical Technologies Corporation is set to release its financial results for the fiscal third quarter ended June 30, 2025, on August 14, 2025, before market open [1] Financial Results Announcement - The company will host an investor conference call and webcast on August 14, 2025, at 8:30 a.m. Eastern time to discuss the financial results and provide a corporate update [2] - Participants can join the call using specific dial-in numbers and access codes provided [2] Call Playback Information - A playback of the conference call will be available until August 28, 2025, with specific numbers for U.S. and international listeners [3] Company Overview - NeuroOne is focused on developing minimally invasive and high-definition solutions for EEG recording, brain stimulation, and ablation for neurological disorders such as epilepsy, Parkinson's disease, and chronic pain [4] - The company may also explore applications in other areas including depression, mood disorders, and artificial intelligence [4]

Core Viewpoint - NeuroOne Medical Technologies Corporation is set to release its financial results for the fiscal second quarter ending March 31, 2025, on May 13, 2025, before market open [1] Group 1: Financial Results Announcement - The financial results will be discussed in an investor conference call and webcast scheduled for May 13, 2025, at 8:30 a.m. Eastern time [2] - Participants can join the call using specific dial-in numbers and access codes provided [2] Group 2: Company Overview - NeuroOne is focused on developing minimally invasive and high-definition solutions for EEG recording, brain stimulation, and ablation for patients with neurological disorders [4] - The company aims to improve patient outcomes and reduce procedural costs, with potential applications in various areas including depression, mood disorders, and high blood pressure [4]